Works matching IS 11732563 AND DT 2022 AND VI 42 AND IP 12

Results: 10

Depicting Risperidone Safety Profiles in Clinical Trials Across Different Diagnoses Using a Dopamine D<sub>2</sub>-Based Pharmacological Class Effect Query Defined by FAERS.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 12, p. 1113, doi. 10.1007/s40261-022-01218-7

By:

Hopkins, Seth C.;
Ogirala, Ajay;
Zeni, Courtney;
Worden, MaryAlice;
Koblan, Kenneth S.

Publication type:

Article

Cost-Utility Analysis Comparing Direct Oral Anticoagulant and Low Molecular Weight Heparin Therapies for Secondary Prevention of Cancer-Associated Thrombosis.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 12, p. 1075, doi. 10.1007/s40261-022-01217-8

By:

Shin, Young Eun;
Kumar, Arun;
Hwang, Monica;
Mackey, Martha;
Wu, Wenchen

Publication type:

Article

Acknowledgement to Referees.

Published in:: Clinical Drug Investigation, 2022, v. 42, n. 12, p. 1021, doi. 10.1007/s40261-022-01225-8
Publication type:: Article

SGLT2 Inhibitors Improve Cardiac Failure by Reducing Whole-Body Oxygen Demand: A Hypothesis.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 12, p. 1025, doi. 10.1007/s40261-022-01220-z

By:

Onoue, Takeshi;
Kataoka, Masaharu

Publication type:

Article

Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 12, p. 1049, doi. 10.1007/s40261-022-01219-6

By:

Durga, Devarapalli Ranjani;
Mounika, Nadella;
Mudimala, Pravallika;
Adela, Ramu

Publication type:

Article

COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 12, p. 1065, doi. 10.1007/s40261-022-01216-9

By:

Ferrara, Francesco;
Mancaniello, Carolina;
Varriale, Alessia;
Sorrentino, Sarah;
Zovi, Andrea;
Nava, Eduardo;
Trama, Ugo;
Boccellino, Mariarosaria;
Vitiello, Antonio

Publication type:

Article

The Effect of Nitazoxanide on the Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 12, p. 1031, doi. 10.1007/s40261-022-01213-y

By:

Abuelazm, Mohamed;
Ghanem, Ahmed;
Awad, Ahmed K.;
Farahat, Ramadan Abdelmoez;
Labieb, Fatma;
Katamesh, Basant E.;
Abdelazeem, Basel

Publication type:

Article

Budget Impact Analysis of Idecabtagene Vicleucel for the Treatment of Adult Patients with Relapsed or Refractory Multiple Myeloma in the US.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 12, p. 1085, doi. 10.1007/s40261-022-01215-w

By:

Ghanem, Buthainah;
Shi, Lu

Publication type:

Article

Pharmacokinetics of Morphine Sulfate Orodispersible Tablets and Bioequivalence with Immediate-Release Oral Morphine Sulfate Formulations in Healthy Adult Subjects Under Fasting Conditions: Single-Dose Comparative Bioavailability Studies.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 12, p. 1101, doi. 10.1007/s40261-022-01214-x

By:

Atrux-Tallau, Nicolas;
Naimi, Zulaikha;
Jaudinot, Eric-Olivier

Publication type:

Article

Pharmacokinetics of Glepaglutide, A Long-Acting Glucagon-Like Peptide-2 Analogue: A Study in Healthy Subjects.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 12, p. 1093, doi. 10.1007/s40261-022-01210-1

By:

Agersnap, Mikkel Askjær;
Sonne, Kim;
Knudsen, Kim Mark;
Knudsen, Carsten Boye;
Berner-Hansen, Mark

Publication type:

Article